Evidence map›Paper›PMID 41848375›Full record

ArticleJournal of Alzheimer's disease : JAD2026

Immunoglobulin allotypes and

Janardan P Pandey, Aryan M Namboodiri, Paul J Nietert

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Janardan P PandeyDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0001-9992-4737
Aryan M NamboodiriDepartment of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, USA.
Paul J NietertDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.ORCID 0000-0002-3933-4986

Funding

The Goizueta Alzheimer's Disease Research CenterP30AG066511 · NIA · EMORY UNIVERSITY · PI ALLAN I LEVEY · 2020 to 2026
$29.0M
Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's DiseaseR01AG080451 · NIA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JANARDAN P PANDEY · 2023 to 2026
$1.5M
NIA NIH HHS P30 AG066511NIA NIH HHS R01 AG080451
6 · The paper itself

Abstract

BackgroundIncreasing evidence implicates herpes simplex virus type 1 (HSV1) in the pathogenesis of Alzheimer's disease (AD). The genome-wide association studies have not detected any genes regulating antibody responses to HSV1.ObjectiveTo determine whether the magnitude of antibody responses to HSV1 and to its glycoprotein D (gD) differed between AD patients and controls. Using a candidate gene approach, determine if the antibody responses were associated with immunoglobulin GM (γ marker) and KM (κ marker) allotypes-hereditary antigenic determinants of γ and κ chains, respectively. We also aimed to determine whether GM and KM allotypes epistatically interacted with an AD risk gene-reelin-encoding

Indexed as

Alzheimer DiseaseHerpesvirus 1, HumanImmunity, HumoralImmunoglobulin Gm AllotypesImmunoglobulin Km AllotypesNerve Tissue ProteinsAgedAged, 80 and overAllelesAntibodies, ViralFemaleGenotypeHumansImmunoglobulin GMalePolymorphism, Single NucleotideAntibodies, ViralImmunoglobulin GImmunoglobulin Gm AllotypesImmunoglobulin Km AllotypesNerve Tissue ProteinsReelin ProteinRELN protein, humanAlzheimer's diseaseGM and KM allotypesHSV1immunityRELN

Identifiers

PMID41848375
PMCPMC13217300

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.